ASCO GI 2024

January 18-20, 2024
San Francisco, CA

ASCO Gastrointestinal Cancer Symposium 2024

Explore more Oncology congress materials

Results(1)

Hematology-Oncology

Zanidatamab in Previously-Treated HER2-Positive Biliary Tract Cancer (BTC): Impact on Patient-Reported Pain Outcomes in the Phase 2b HERIZON-BTC-01 Study

Author(s): Shubham Pant, MD Anderson Cancer Center, et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.